Total Payments
$73,673
2024 Payments
$62.92
Companies
37
Transactions
212
Medicare Patients
458
Medicare Billing
$53,015
Payment Breakdown by Category
Research$36,669 (49.8%)
Other$31,500 (42.8%)
Food & Beverage$3,386 (4.6%)
Travel$2,114 (2.9%)
Education$3.87 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $36,669 | 5 | 49.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31,500 | 10 | 42.8% |
| Food and Beverage | $3,386 | 181 | 4.6% |
| Travel and Lodging | $2,114 | 15 | 2.9% |
| Education | $3.87 | 1 | 0.0% |
Payments by Type
General
$37,004
207 transactions
Research
$36,669
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TARO PHARMACEUTICALS USA, INC. | $36,669 | 5 | $0 (2017) |
| Galderma Laboratories, L.P. | $34,531 | 47 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $728.37 | 40 | $0 (2024) |
| Amgen Inc. | $247.03 | 16 | $0 (2020) |
| Allergan, Inc. | $176.08 | 13 | $0 (2020) |
| GlaxoSmithKline, LLC. | $110.59 | 6 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $97.00 | 6 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $84.65 | 5 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $77.53 | 9 | $0 (2020) |
| Lilly USA, LLC | $70.11 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62.92 | 4 | AstraZeneca Pharmaceuticals LP ($30.92) |
| 2023 | $54.45 | 3 | AstraZeneca Pharmaceuticals LP ($22.01) |
| 2022 | $46.20 | 3 | Neuronetics, Inc. ($20.00) |
| 2020 | $309.56 | 18 | AstraZeneca Pharmaceuticals LP ($113.08) |
| 2019 | $323.40 | 18 | AstraZeneca Pharmaceuticals LP ($144.93) |
| 2018 | $16,959 | 70 | Galderma Laboratories, L.P. ($16,249) |
| 2017 | $55,918 | 96 | TARO PHARMACEUTICALS USA, INC. ($36,669) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Oncology | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Respiratory | ||||||
| 02/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Obesity | ||||||
| 10/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes | ||||||
| 07/17/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Oncology | ||||||
| 02/27/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Respiratory | ||||||
| 12/06/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: VACCINES | ||||||
| 08/20/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 12/16/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2020 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: HIV | ||||||
| 11/30/2020 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Neuroscience | ||||||
| 10/01/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/01/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/11/2020 | Romark Laboratories, LC | ALINIA (Drug), ALINIA, ALINIA | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Gastroenterology | ||||||
| 07/02/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TaroAZAG 1533 | TARO PHARMACEUTICALS USA, INC. | $30,145 | 4 |
| TaroAZAF 1703 | TARO PHARMACEUTICALS USA, INC. | $6,524 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 131 | 237 | $58,828 | $18,301 |
| 2022 | 4 | 70 | 124 | $32,802 | $11,018 |
| 2021 | 2 | 38 | 54 | $7,580 | $3,114 |
| 2020 | 7 | 219 | 483 | $49,930 | $20,581 |
Total Patients
458
Total Services
898
Medicare Billing
$53,015
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 100 | $29,200 | $8,198 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 82 | $16,892 | $5,057 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $4,768 | $2,012 | 42.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $4,512 | $1,938 | 43.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 27 | $3,456 | $1,097 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 52 | $15,184 | $4,920 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 47 | $9,682 | $3,408 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,888 | $1,686 | 34.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,048 | $1,004 | 32.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 34 | $4,080 | $1,756 | 43.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 20 | $3,500 | $1,359 | 38.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 146 | $25,550 | $10,969 | 42.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 61 | 173 | $20,760 | $8,939 | 43.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 12 | 33 | $1,650 | $337.53 | 20.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 48 | 73 | $730.00 | $217.92 | 29.9% |
| 81003 | Automated urinalysis test | Office | 2020 | 19 | 28 | $280.00 | $62.25 | 22.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 11 | 15 | $810.00 | $53.67 | 6.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 11 | 15 | $150.00 | $1.11 | 0.7% |
About Dr. Gregory Samano, DO
Dr. Gregory Samano, DO is a Family Medicine healthcare provider based in Altamonte Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205804226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Samano, DO has received a total of $73,673 in payments from pharmaceutical and medical device companies, with $62.92 received in 2024. These payments were reported across 212 transactions from 37 companies. The most common payment nature is "" ($36,669).
As a Medicare-enrolled provider, Samano has provided services to 458 Medicare beneficiaries, totaling 898 services with total Medicare billing of $53,015. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Altamonte Springs, FL
- Active Since 03/08/2006
- Last Updated 02/11/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1205804226
Products in Payments
- Topicort Spray 0.25% (Drug) $36,669
- FARXIGA (Drug) $536.47
- Aimovig (Biological) $129.86
- XIFAXAN (Drug) $110.85
- Prolia (Biological) $88.67
- Trintellix (Drug) $80.07
- VIBERZI (Drug) $77.23
- BRILINTA (Drug) $75.29
- VYVANSE (Drug) $69.52
- SOLIQUA (Drug) $67.93
- BREO (Drug) $65.85
- TRULICITY (Drug) $55.20
- VRAYLAR (Drug) $40.23
- CONTRAVE (Drug) $37.49
- JARDIANCE (Drug) $36.20
- BEVESPI AEROSPHERE (Drug) $36.01
- LINZESS (Drug) $35.19
- CHANTIX (Drug) $34.90
- Cologuard Collection Kit (Device) $33.92
- AFREZZA (Drug) $33.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Altamonte Springs
Andrew Krupitsky, Do, DO
Family Medicine — Payments: $13,580
Family Medicine $13,580
Britney Huneycutt, Do, DO
Family Medicine — Payments: $13,055
Family Medicine $13,055
Dr. Ashton Brinson, Md, MD
Family Medicine — Payments: $9,213
Family Medicine $9,213
Deanna Tran, D.o, D.O
Family Medicine — Payments: $5,858
Family Medicine $5,858
Kyme Clinton, Do, DO
Family Medicine — Payments: $3,825
Family Medicine $3,825
James Badman, Md, MD
Family Medicine — Payments: $3,253
Family Medicine $3,253